Syncom Formulations (India) Limited manufactures pharmaceutical formulation products in India. It offers various products, including generics, alpha adrenoceptor agonists, analgesics, antipyretics, anti-inflammatory, anti-ulcer agents, antibiotics, antidepressants, antifungals, antihistamines, antimalarial, antiplatelet agents, antiprotozoal, antivirals, bronchodilators, calcium antagonists, cardiac medicines, central nervous stimulants, cephelo sporins, cortico steroids, estrogen, cough suppressants, erectile dysfunction, and electrolite. The company also provides histamines, homeostatic, hypoglycemic, hypolipidaemics, local anesthetics, multivitamins and nutritional supplements, sedative anticonvulsants, stimulants, and sympathomimetic products, as well as products used in the treatment of gout. In addition, it engages in the trading of commodities and renting of properties. Syncom Formulations (India) Limited offers its pharmaceutical formulations in various forms, such as tablets, capsules, liquids orals, liquid vials and ampoule injections and dry vial injections, dry syrups, ointments, and inhalers and herbals. Further, the company exports its products. Syncom Formulations (India) Limited was founded in 1985 and is based in Indore, India.